Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Temecula, CA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Temecula, CA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Lauderhill, FL
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Lauderhill, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Miami, FL
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
North Miami, FL
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
North Miami, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Oakland Park, FL
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oakland Park, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Atlanta, GA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Augusta, GA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Augusta, GA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Decatur, GA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Flowood, MS
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Flowood, MS
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Creve Coeur, MO
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
O'Fallon, MO
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
O'Fallon, MO
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Saint Louis, MO
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Las Vegas, NV
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Berlin, NJ
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Marlton, NJ
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Marlton, NJ
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Brooklyn, NY
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Jamaica, NY
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Jamaica, NY
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
New York, NY
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Rochester, NY
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Canton, OH
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Canton, OH
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Dayton, OH
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Middleburg Heights, OH
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Allentown, PA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Allentown, PA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Austin, TX
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Desoto, TX
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Desoto, TX
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Houston, TX
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Bellevue, WA
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
San Juan,
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
San Juan,
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Washington,
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Washington,
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Tampa, FL
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Grand Rapids, MI
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Wards Island, NY
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Wards Island, NY
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1171
mi
from
Rochester, NY
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1171
mi
from
Rochester, NY
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1041
mi
from
Cerritos, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1041
mi
from
Cerritos, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1062
mi
from
Costa Mesa, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1062
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1104
mi
from
Garden Grove, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1104
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1118
mi
from
Glendale, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1118
mi
from
Glendale, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1114
mi
from
National City, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1114
mi
from
National City, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1368
mi
from
Orange, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1368
mi
from
Orange, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1399
mi
from
Orange, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1399
mi
from
Orange, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1384
mi
from
Sherman Oaks, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1384
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1392
mi
from
Torrance, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1392
mi
from
Torrance, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1395
mi
from
Bradenton, FL
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1395
mi
from
Bradenton, FL
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1253
mi
from
Jacksonville, FL
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1253
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1130
mi
from
Miami, FL
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1130
mi
from
Miami, FL
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1129
mi
from
North Miami, FL
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1129
mi
from
North Miami, FL
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1318
mi
from
North Miami, FL
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1318
mi
from
North Miami, FL
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1402
mi
from
Oakland Park, FL
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1402
mi
from
Oakland Park, FL
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1009
mi
from
Atlanta, GA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1009
mi
from
Atlanta, GA
Click here to add this to my saved trials